Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 24 Apr 23 424B5 Prospectus supplement for primary offering
- 20 Apr 23 424B5 Prospectus supplement for primary offering
- 20 Dec 22 424B5 Prospectus supplement for primary offering
- 15 Jun 22 424B3 Prospectus supplement
- 3 Dec 21 424B5 Prospectus supplement for primary offering
- 1 Dec 21 424B5 Prospectus supplement for primary offering
- 20 Oct 21 424B5 Prospectus supplement for primary offering
- 30 Aug 21 424B5 Prospectus supplement for primary offering
- 14 Jul 21 EFFECT Notice of effectiveness
- 6 Jul 21 S-3/A Shelf registration (amended)
-
2 Jul 21 S-3 Shelf registration
ADTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 25, 2021 relating to the financial statements of Aditx Therapeutics, Inc. as of and for the years ended December 31, 2020 and 2019 included in its Annual Report on Form 10-K. We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ dbbmckennon |
Newport Beach, California
July 2, 2021